APP-based Emotion Recognition Training Improve ASD Social Function
NCT ID: NCT06421272
Last Updated: 2024-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE1
50 participants
INTERVENTIONAL
2023-01-01
2024-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Plasticity of Autism in Response to Early Behavioral Intervention: A Multimodal MRI Study
NCT02807766
Development of Eye-tracking Based Markers for Autism in Young Children
NCT03286621
Neurotherapy to Promote Emotion Recognition in Autism
NCT03376373
Early Socioemotional Intervention for Children With Autism Spectrum Disorder in Hong Kong and Mainland China
NCT04658043
High Definition Transcranial Direct Current Stimulation of Right Inferior Frontal Gyrus to Improve Social Impairments in Children with Autism
NCT06723522
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APP-based emotion recognition trainning
Experimental group: ASD children were asked to do emotion recognition for eight weeks using iPAD. Two 15-minsute sessions each day was required.
APP-based emotion recognition intervention
ASD children were asked to play emotion recognition-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
APP-based memory training
Control group: ASD children were asked to do memory training (i.e. 1 back) for eight weeks using iPAD. Two 15-minsute sessions each day was required.
APP-based memory intervention
ASD children were asked to play memory-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
APP-based emotion recognition intervention
ASD children were asked to play emotion recognition-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
APP-based memory intervention
ASD children were asked to play memory-related games for eight weeks using iPAD. Two 15-minsute sessions each day was required.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
4 Years
10 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Electronic Science and Technology of China
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Weihua Zhao
Associate Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Electronic Science and Technology
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UESTC-neuSCAN-94
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.